Tratamiento con Amlodipina de la hipertensión arterial esencial leve/moderada

Amado, Marco Tulio; Guerra Palma, Gabriel Alejandro.
Rev. méd. Costa Rica ; 60(525): 161-5, oct.-dic. 1993.
Artículo en Español | LILACS | ID: lil-140947

Documentos relacionados

  1. The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022.
  2. Cilnidipine: Next Generation Calcium Channel Blocker.
  3. New Insights into the Nephroprotective Potential of Lercanidipine.
  4. Effects of Dihydropyridines on the Motor and Cognitive Outcomes of Patients with Parkinson's Disease.
  5. A Retrospective Study to Evaluate Real-world Evidence of Azelnidipine in Indian Patients (REDEFINE Study).
  6. Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND.
  7. Role Of Efonidipine In CKD Patients : A Study in North Bihar.
  8. Access to Highly Enantioenriched Donepezil-like 1,4-Dihydropyridines as Promising Anti-Alzheimer Prodrug Candidates via Enantioselective Tsuji Allylation and Organocatalytic Aza-Ene-Type Domino Reactions.
  9. [Treatment of patients with arterial hypertension in clinical practice in 2010-2020 (according to the national register of hypertension)].
  10. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.